Aztreonam for inhalation solution in patients with non-cystic fibrosis bronchiectasis (AIR-BX1 and AIR-BX2): two randomised double-blind, placebo-controlled phase 3 trials - Barker, A F; OʼDonnell, A E; Flume, P (Lancet Respir Med, 2014)